Eli Lilly releases cheaper vials of the weight-loss drug for self-paying patients and cuts the price of two existing doses.

Stock in Hims & Hers Health was bound to tumble once it [could no longer sell]( ...

Super Micro has until Tuesday to file delayed financial accounts or risk being delisted by the Nasdaq stock exchange, Home ...

Hims & Hers expects revenue from its weight loss business to soar in 2025, even though a recent FDA move could make it ...

Hims & Hers, a leading health care platform, has been making waves with its impressive Q4 2024 earnings report. In a recent ...